Outset Medical Inc Cash Flow Conversion Efficiency
Outset Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Outset Medical Inc (OM) has a cash flow conversion efficiency ratio of -0.100x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.63 Million) by net assets ($96.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Outset Medical Inc (2018–2025)
Cash flow conversion efficiency of Outset Medical Inc from 2018 to 2025. This chart illustrates how Outset Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Outset Medical Inc stock price today for real-time trading data and today's change.
Outset Medical Inc Cash Flow Conversion Ratio Explained
Outset Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Outset Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Outset Medical Inc ranked by their cash flow conversion efficiency. Also see Outset Medical Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rimbunan Sawit Bhd
KLSE:5113
|
0.112x |
|
POLARIS WORKS Inc
KQ:123010
|
0.019x |
|
ALT5 Sigma Corporation
NASDAQ:ALTS
|
-0.014x |
|
Daehan Synthet
KO:003830
|
-0.005x |
|
Cisadane Sawit Raya Pt
JK:CSRA
|
0.085x |
|
Summit State Bank
NASDAQ:SSBI
|
0.043x |
|
Air T Inc
NASDAQ:AIRT
|
-0.034x |
|
Apollo Silver Corp
V:APGO
|
-0.027x |
Annual Cash Flow Conversion Efficiency for Outset Medical Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Outset Medical Inc from 2018 to 2025. Review Outset Medical Inc (OM) flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $126.95 Million | $-46.33 Million | -0.365x | +91.59% |
| 2024-12-31 | $26.82 Million | $-116.30 Million | -4.337x | -305.64% |
| 2023-12-31 | $122.89 Million | $-131.37 Million | -1.069x | -80.46% |
| 2022-12-31 | $245.99 Million | $-145.73 Million | -0.592x | -70.13% |
| 2021-12-31 | $374.08 Million | $-130.26 Million | -0.348x | -15.57% |
| 2020-12-31 | $328.61 Million | $-99.02 Million | -0.301x | -259.54% |
| 2019-12-31 | $-372.19 Million | $-70.29 Million | 0.189x | +17.10% |
| 2018-12-31 | $-287.95 Million | $-46.44 Million | 0.161x | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more